L23 - Parkinsons Disease Flashcards
(25 cards)
Huntingtons Disease is due to a single gene where else PD is due to a whole range of factors. Normally, DA neurons have a tonic inhibition over ACh neurons,
Huntingtons Disease is due to a single gene where else PD is due to a whole range of factors. Normally, DA neurons have a tonic inhibition over ACh neurons,
PD motor symptoms
Bradykinesia
Rigid limbs
Decreased manual dexterity
Postural reflex impairment
Impassive face - no blinking
Tremor
Speech - monotonous, hypophonic (soft)
List some non-motor PD symptoms - which is the first one a PD person exp?
Olfactory deficiencies and bowel problems
Fatigue
Anxiety
Cognitive deficiencies
Depression
Insomnia
Pain
Sex dsyfunction
In PD what bodies are present at post-mortem?
Lewy bodies - abnormal aggregates of protein that develop inside nerve cells and cause toxicity
In PD, there is a mutation in parkin - what is it and how does it affect the cell?
Ubiquitin ligase
Ubiquitin is a tag that initiates protein degradation. If parkin is affected, proteins can’t get degraded and the cell gets filled up and apoptosis occurs
What role does DJ-1 and PINK-1 play in PD?
Involved in mitochondria - mutations in these 2 genes lead to an increased amount of ROS = death
Since PD people lack DA, would amphetamine and cocaine help?
No - as it has many other effects as well
How does a cholinergic antagonist help treat PD? Musc or nic?
In the microanatomy of the CNS, DA has a tonic inhibition on Cholinergic neurons. As there is decreased DA neurons in PD, hence also a decrease in the inhibition of Cholinergic neurons.
Musc
L-Dopa have over 90% of it metabolised in the periphery after it is converted into DA - mainly by ___ and some by ___-
Mainly by gut and some in peripheral tissues
List 2 DDC inhibitors
Carbidopa
Benserazide
Why does treatment using Carbidopa.Benserazide and L-Dopa decline over time?
PD symptoms exhibited when you’ve lost 60-80% of DA neurons - treatment requires functional DA neurons. Treatment declines over time as you lose more and more DA neurons overtime
The more drugs you take - it accelerates PD in some people because you are using the DA neurons
What is Levodopa? Half-life? Side effects?
L-Dopa
1-2 hours - rapid absorption on empty stomach as it competes with other neutral a.acids
SE - anorexia, nausea, tachycardia, orthostatic hypotension, pupil dilation
List 2 DA agonists
Bromocriptine
Cabergoline
What ergoline-based DA agonist can be used in adjunct to L-Dopa?
Pergolide
Why is MAOB inhibitor preferred over MAOA inhibitor?
MAOA inhibitor may cause hypertension
*Early use may delay disease progression by reducing formation of free radicals
What drug is currently used as antiviral in influenza that enhances DA release?
Amantadine
- Less efficacious than L-DOPA and more rapid tolerance
- Has anticholinergic activity
T/F - Deep brain stimulation works for PD patients
T
What receptor antagonists interact with D2 receptors in basal ganglia to make the D2 receptors more sensitive to DA?
Adenosine A2a
By antagonising ____, L-Dopa will be able to be used at a higher dose?
mGluR5
2 suggestions to treat PD 5-10 years from now? 10-20 years?
Deep brain stimulation (DBS) and optogentics
Genetics, cell replacement therapy (induced pluripotent stem cells) - take a skin cell from patient and reprogram it then use another mix of genes to turn it into DA neuron (these cells avoid transplant rejection but also may be susceptible to the same disease process)
What is the number 1 mutation in PD?
Alpha-synuclein - thread-like fibrils of stuck-together copies of this protein are found in Lewy body deposits inside neurons in affected brain areas
- Mutating or overproducing a-synuclein can cause PD
- small not large fibrils are the real toxic drivers of the disease
- Oxidized DA enhances stability of a-synuclein oligomers (bad thing)
T/F - Smoking and drinking have been linked to lower incidence of PD (no one knows why)
T
What is an early non-motor sign of PD
Gut and nose being affected
Number 1 risk factor for PD
Age - could weaken mitochondria and reduce neuron’s ability to dispose of harmful alpha-synuclein aggregates